Lamzede Market Report 2026

Lamzede Market Overview

• The Lamzede market growth in the historic period has been driven by advances in rare disease diagnostics, regulatory approvals for orphan drugs • Market expansion is supported by expansion of newborn screening programs, development of next-generation enzyme therapies • Growth Driver: Rising Prevalence Of Rare Genetic Disorders Driving The Market Growth • Market Trend: Advancements In Enzyme Replacement Therapy For Rare Genetic Disorders • Europe was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lamzede Market?

Lamzede is a recombinant human alpha-mannosidase enzyme used in enzyme replacement therapy for alpha-mannosidosis, a rare genetic disorder. It helps break down mannose-rich oligosaccharides, whose accumulation causes tissue and organ damage. By addressing this enzyme deficiency, Lamzede alleviates symptoms, improves mobility, reduces fatigue, and enhances overall quality of life. The main formulations of lamzede are injectable formulation (intravenous) and lyophilized powder for reconstitution. The injectable formulation of Lamzede, administered intravenously every week, ensures effective delivery to treat non-central nervous system symptoms of alpha-mannosidosis. It is applicable in various indications, such as the treatment of alpha-mannosidosis and the management of symptoms associated with alpha-mannosidosis for several patient demographics, including pediatric patients, adult patients, and geriatric patients. It is distributed through various distribution channels, such as direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies, and is used by several end users, including hospitals, specialty clinics, home healthcare providers, and research institutions.

What Is The Lamzede Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of newborn screening programs, development of next-generation enzyme therapies, rising focus on long-term disease management, increased access to orphan drug reimbursement, growth in personalized rare disease care. Major trends in the forecast period include increasing adoption of enzyme replacement therapies, expansion of treatments for lysosomal storage disorders, growing focus on early diagnosis of rare diseases, enhanced development of recombinant enzymes, rising patient-centric therapy approaches.

What Are The Drivers Of The Lamzede Market?

The rising prevalence of rare genetic disorders is expected to propel the growth of the lamzede market going forward. Rare genetic disorders are diseases resulting from genetic mutations that are uncommon in the population, often resulting in distinctive or serious health issues. The prevalence of rare genetic disorders is attributed to advancements in genetic testing, increased awareness and diagnosis, and improved research technologies. Lamzede helps manage rare genetic disorders by providing a synthetic enzyme to break down accumulated sugars, alleviating symptoms. It improves motor and cognitive function, slows disease progression, and enhances quality of life. For instance, in December 2024, according to Clinical Trials Arena, a UK-based clinical research news platform, hospital admissions of Mycoplasma pneumoniae increased by 461% from October 2023 to February 2024, rising from 110 to 617 admissions. Therefore, the rising prevalence of rare genetic disorders is driving the growth of the lamzede industry. The increasing focus on personalized medicine is set to propel the growth of the Lamzede market moving forward. Personalized medicine refers to a medical approach that customizes healthcare treatments based on an individual's unique genetic makeup, environment, and lifestyle. The demand for personalized therapies is attributed to factors such as advancements in genetic research, a better understanding of diseases at the molecular level, and improved diagnostic tools. Lamzede supports personalized medicine by offering targeted treatment for rare genetic disorders like alpha-mannosidosis, addressing specific enzyme deficiencies. It tailors therapy to an individual's genetic profile for more effective management of the condition. For instance, in February 2024, the Personalized Medicine Coalition, a US-based organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, marking a notable rise from the six approvals in 2022. Therefore, increasing focus on personalized medicine is driving the growth of the lamzede industry.

Key Players In The Global Lamzede Market

Major companies operating in the lamzede market are Chiesi Farmaceutici S.p.A.

Global Lamzede Market Trends and Insights

The key trend in the lamzede market is the emphasis on developing advanced therapies, such as enzyme replacement therapy (ERT), to address the growing demand for effective treatments for rare genetic disorders. ERT is a medical approach in which missing or deficient enzymes are replaced in the body to treat specific genetic conditions, usually lysosomal storage diseases, through the administration of synthetic versions of these enzymes. For instance, in February 2023, Chiesi Global Rare Diseases, a US-based biopharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for Lamzede (velmanase alfa-tycv) for the treatment of non-central nervous system manifestations of alpha-mannosidosis (AM) in both adult and pediatric patients. This recombinant form of human alpha-mannosidase helps to supplement the enzyme α-mannosidase, preventing the accumulation of mannose-rich oligosaccharides in the body. Lamzede addresses symptoms such as hearing loss, muscle weakness, and skeletal abnormalities, offering a significant treatment option for this ultra-rare, progressive lysosomal storage disorder.

What Defines the Lamzede Market?

The lamzede market consists of sales of pre-filled syringes, liquid vial formulations, and oral dissolvable tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lamzede Market Report 2026?

The lamzede market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lamzede industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.